B

Biohaven Ltd

D
BHVN
USD
0.97
(2.4619%)
Market Closed
41,703.00
Volume
-8.769
EPS
-
Div Yield
-4.340860
P/E
3,816,670,753.61
Market Cap
Today
2.4619%
1 Week
12.955%
1 Month
1.611%
6 Months
-29.110%
12 Months
123.533%
Year To Date
-5.678%
All Time
0%

Title:
Biohaven Ltd

Sector:
Healthcare
Industry:
Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Do you need help or have a question?